Title : Pharmacokinetic and pharmacodynamic interactions between almorexant, a dual orexin receptor antagonist, and desipramine.

Pub. Date : 2014 Aug

PMID : 24880753






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Desipramine was selected as a model drug because it is mainly metabolized by CYP2D6, which is inhibited by almorexant in vitro. Desipramine cytochrome P450 family 2 subfamily D member 6 Homo sapiens
2 Almorexant increased the exposure to desipramine 3.7-fold, suggesting that almorexant is a moderate inhibitor of desipramine metabolism through inhibition of CYP2D6. Desipramine cytochrome P450 family 2 subfamily D member 6 Homo sapiens
3 Almorexant increased the exposure to desipramine 3.7-fold, suggesting that almorexant is a moderate inhibitor of desipramine metabolism through inhibition of CYP2D6. Desipramine cytochrome P450 family 2 subfamily D member 6 Homo sapiens